For: |
Zou XP, Dai WJ, Cao J. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i42/5340.htm |
Number | Citing Articles |
1 |
David Emmanuel Kubelis-López, Natalia Aranza Zapata-Salazar, Mauricio Andrés Salinas-Santander, Celia Nohemí Sánchez-Domínguez, Jesús Antonio Morlett-Chávez, Jorge Ocampo-Candiani. Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo. Anais Brasileiros de Dermatologia 2023; 98(3): 376 doi: 10.1016/j.abd.2022.07.003
|
2 |
Ming‐Hsien Chien, Kun‐Tu Yeh, Yi‐Ching Li, Yi‐Hsien Hsieh, Chien‐Huang Lin, Meng‐Shih Weng, Wu‐Hsien Kuo, Shun‐Fa Yang. Effects of E‐cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma. Journal of Surgical Oncology 2011; 104(3): 299 doi: 10.1002/jso.21929
|
3 |
Qiqi Jiang, Peizhen Geng, Yuying Zhang, Maoquan Yang, Jiafeng Zhu, Mingwei Zhang, Yamei Wang, Yikuan Feng, Xiaojuan Sun. Associations between CDH1 gene polymorphisms and the risk of gastric cancer: A meta-analysis based on 44 studies. Medicine 2024; 103(23): e38244 doi: 10.1097/MD.0000000000038244
|
4 |
Gongcheng Li, Tiejun Pan, Dan Guo, Long-Cheng Li. Regulatory Variants and Disease: The E-Cadherin −160C/A SNP as an Example. Molecular Biology International 2014; 2014: 1 doi: 10.1155/2014/967565
|
5 |
Ramin Shekarriz, Reza Alikhani, Mohaddeseh Ghasemi, Reza Alizadeh Navaei, Mohammad Bagher Hashemi-Soteh. Correlation of –160C > A and –347GA > G polymorphisms in E-cadherin gene and gastric cancer in north of Iran. Journal of Research in Medical Sciences 2021; 26(1): 3 doi: 10.4103/jrms.JRMS_50_20
|
6 |
Chun‐Cui Ye, Jun Wang. E‐cadherin (CDH1) gene –160C/A polymorphism and the risk of colorectal cancer: A meta‐analysis involving 17,291 subjects. The Journal of Gene Medicine 2021; 23(10) doi: 10.1002/jgm.3370
|
7 |
Ming‐Hsien Chien, Lin Shih‐Shen Chou, Tsung‐Te Chung, Chien‐Huang Lin, Ming‐Yung Chou, Meng‐Shih Weng, Shun‐Fa Yang, Mu‐Kuan Chen. Effects of E‐cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer. Head & Neck 2012; 34(3): 405 doi: 10.1002/hed.21746
|
8 |
Andrés Felipe Aristizábal-Pachón, Catarina Satie Takahashi. Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin–E in breast cancer susceptibility. Biomédica 2016; 36(4): 593 doi: 10.7705/biomedica.v36i4.3135
|
9 |
Li-Li Zhang, Xue-Jun Tang, Xiao-Yun Wang, Ying-Wei Zhu, Xiao-Bin Peng, Lei Gong. A promoter polymorphism in the hMLH1 gene (−93G/A) associated with sporadic colorectal cancer. Oncology Letters 2016; 12(5): 4035 doi: 10.3892/ol.2016.5188
|
10 |
Adem Akçakaya, Nurcan Ünver, Tuğba Aydoğan Kiriş, Mehmet Güzel, Fatma Betül Akçakaya, Bedia Çakmakoğlu, Mustafa Hasbahçeci. Association of CDH1 -160 C → A and -347 G→ GA polymorphisms and expression of E-cadherin and gastric cancer: A case-control study. Turkish Journal of Surgery 2021; 37(1): 41 doi: 10.47717/turkjsurg.2021.5097
|
11 |
Yadong Wang, Haiyan Yang, Li Li, Haiyu Wang, Congke Zhang, Xiangqun Xia. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer. International Journal of Colorectal Disease 2012; 27(2): 151 doi: 10.1007/s00384-011-1320-7
|